Guggenheim Assumes Merck (MRK) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $147.37 -1.44%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 20 | New: 16
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 20 | New: 16
Join SI Premium – FREE
Guggenheim analyst Vamil Divan assumes coverage on Merck (NYSE: MRK) with a Buy rating and a price target of $142.00.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $127.76 yesterday.
You May Also Be Interested In
- Merck (MRK) PT Raised to $171 at Guggenheim
- Merck (MRK) PT Raised to $165 at BofA Securities
- Merck (MRK) PT Lowered to $140 at RBC Capital
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
